ISRG — Intuitive Surgical Share Price
Last trade - 00:00- $172.95bn
- $168.90bn
- $8.35bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 57 | ||
| PEG Ratio (f) | 3.11 | ||
| EPS Growth (f) | 22.42% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 10.52 | ||
| Price to Tang. Book | 10.77 | ||
| Price to Free Cashflow | 132.65 | ||
| Price to Sales | 20.71 | ||
| EV to EBITDA | 59.29 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.82% | ||
| Return on Equity | 15.62% | ||
| Operating Margin | 28.12% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 4,358.4 | 5,710.1 | 6,222.2 | 7,124.1 | 8,352.1 | 9,591.87 | 11,084.78 | 13.27% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -22.73 | +57.6 | -21.08 | +36.93 | +27.03 | +25.16 | +17.28 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Directors
- Craig Barratt NEC (58)
- Gary Guthart CEO (55)
- Jamie Samath CFO (51)
- Myriam Curet EVP (64)
- Bob DeSantis EVP (55)
- Marshall Mohr EVP (65)
- David Rosa EVP (53)
- Kara Andersen Reiter SVP (56)
- Joseph Beery IND (49)
- Amal Johnson IND (68)
- Don Kania IND (66)
- Amy Ladd IND (63)
- Keith Leonard IND (59)
- Alan Levy IND (83)
- Jami Nachtsheim IND (62)
- Mark Rubash IND (64)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 9th, 1995
- Public Since
- June 13th, 2000
- No. of Shareholders
- 124
- No. of Employees
- 15,638
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 358,274,567
- Address
- 1020 Kifer Road, SUNNYVALE, 94086
- Web
- https://www.intuitive.com/en-us/about-us/company
- Phone
- +1 4085232100
- Auditors
- PricewaterhouseCoopers LLP
Latest News for ISRG
Upcoming Events for ISRG
Q1 2025 Intuitive Surgical Inc Earnings Call
Q1 2025 Intuitive Surgical Inc Earnings Release
Intuitive Surgical Inc Annual Shareholders Meeting
Intuitive Surgical Inc Annual Shareholders Meeting
Q2 2025 Intuitive Surgical Inc Earnings Release
Q3 2025 Intuitive Surgical Inc Earnings Release
Similar to ISRG
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
As of Today at 21:21 UTC, shares in Intuitive Surgical are trading at $482.74. This share price information is delayed by 15 minutes.
Shares in Intuitive Surgical last closed at $482.74 and the price had moved by +29.02% over the past 365 days. In terms of relative price strength the Intuitive Surgical share price has outperformed the S&P500 Index by +21.31% over the past year.
The overall consensus recommendation for Intuitive Surgical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreIntuitive Surgical does not currently pay a dividend.
Intuitive Surgical does not currently pay a dividend.
Intuitive Surgical does not currently pay a dividend.
To buy shares in Intuitive Surgical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $482.74, shares in Intuitive Surgical had a market capitalisation of $172.95bn.
Here are the trading details for Intuitive Surgical:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: ISRG
Based on an overall assessment of its quality, value and momentum Intuitive Surgical is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Intuitive Surgical is $624.07. That is 29.28% above the last closing price of $482.74.
Analysts covering Intuitive Surgical currently have a consensus Earnings Per Share (EPS) forecast of $8.05 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Intuitive Surgical. Over the past six months, its share price has outperformed the S&P500 Index by +2.65%.
As of the last closing price of $482.74, shares in Intuitive Surgical were trading -5.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Intuitive Surgical PE ratio based on its reported earnings over the past 12 months is 57. The shares last closed at $482.74.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Intuitive Surgical's management team is headed by:
- Craig Barratt - NEC
- Gary Guthart - CEO
- Jamie Samath - CFO
- Myriam Curet - EVP
- Bob DeSantis - EVP
- Marshall Mohr - EVP
- David Rosa - EVP
- Kara Andersen Reiter - SVP
- Joseph Beery - IND
- Amal Johnson - IND
- Don Kania - IND
- Amy Ladd - IND
- Keith Leonard - IND
- Alan Levy - IND
- Jami Nachtsheim - IND
- Mark Rubash - IND